News About: Pharm. Industry
Careful approaches are needed over biosimilar business
The government will need to work out measures to push up with the controversial biosimilar business in more cautious manner, experts claimed.
They argued that generic drug companies are ready to make cheaper versio...
107 drugmakers produce cefaclor
A total of 107 pharmaceutical firms are engaged in manufacturing cefaclor, a third-generation antibiotic, according to data of the National Health Insurance Corporation which were released on August 17 frequently pres...
Influenza A benfits biotech firms
As H1N1 influenza claimed the lives of two Koreans over the weekend, shares of biotech companies surged on August 18, although the benchmark KOSPI headed down.
Green Cross Corp., the only Korean company with a faci...
Caspase inhibitor in Phase IIb clinical trial
LG Life Sciences, Ltd. (LGLS) says that its US partner Gilead Sciences is conducting a Phase IIb clinical trial in 240 patients chronically infected with the hepatitis C virus to evaluate caspase inhibitors, which was...
Daewoong’s generic isotretinoin fares well
Daewoong Pharm said its generic isotretinoin has received better recognition from the market due to newly modified PTP (press through pack) package.
The PTP package has contributed much to patients’ compliance and ...
Boryung to build W20 billion cGMP plant
Boryung Pharm said on August 14 it will invest 20 billion won to build a new cGMP plant producing the raw materials of fimasartan, a novel, non-peptide angiotensin II receptor antagonist and other finished products.
...
383 new and chemically modified drugs under development
A total of 383 research projects aiming at developing new and chemically modified medicines have been undertaken by 38 Korean companies, according to a white paper released by the Korea Drug Research Association on Au...
Binex shares boosted by Samsung Electronics acquisition
Shares of Binex Co., a Korean pharmaceutical firm, were boosted on August 13 by expectations that Samsung Electronics Co., the world's second-largest maker of chips and mobile phones, will acquire Binex as part of eff...
92 applicants wait for KGSP accreditation in first half
92 applicants are awaiting the final endorsement of the KGSP (Korea Good Supply Practice) in the first half of this year, according to the Yakup Shinmoon. Applications pending final screening totaled 142 last year.
...
Chong Kun Dang fared well in first half
Chong Kung Dang Pharma made a good start in the first half of this year thanks to robust sales of its leading generic products.
The company garnered 12.5 billion won in sales of Salotane (losartan potassium), a gen...
